...
首页> 外文期刊>International Journal of Pharmacy and Pharmaceutical Sciences >SUSTAINED RELEASE MUCOADHESIVE MICROCAPSULES OF RAMIPRIL BY IONIC GELATION TECHNIQUE: FORMULATION DESIGN, OPTIMIZATION AND CHARACTERIZATION
【24h】

SUSTAINED RELEASE MUCOADHESIVE MICROCAPSULES OF RAMIPRIL BY IONIC GELATION TECHNIQUE: FORMULATION DESIGN, OPTIMIZATION AND CHARACTERIZATION

机译:离子胶凝技术持续释放拉米普尔的微囊微胶囊:配方设计,优化和表征

获取原文

摘要

Objective: The major objective of the research?work was to design, optimise?and?characterise sodium alginate based sustained release mucoadhesive microcapsules of ramipril by ionic gelation method. Methods: An experimental set-up was designed to investigate the optimal combination of mucoadhesive polymers such as carbopol 974P,?HPMC?(K4M and?K100M), Na CMC and chitosan and their drug compatibility with respect to reliabilities. Preliminary screening of the formulation variables was accomplished by Taguchi design followed by Box-Behnken design for systematic optimisation. The suitable mathematical model was selected, response surface analysis was performed and optimised formulation was chosen by numerical optimization and desirability function method. Characterization of the prepared microcapsules for several inherent properties like particle size,?drug content, sphericity,?entrapment efficiency, loose surface crystal study, swelling index, micromeritic properties, moisture content, in vitro drug release, mucoadhesive strength and in vivo antihypertensive?activity was performed. Results: Differential Scanning Calorimetry (DSC) thermograms and Fourier Transform Infra-Red (FT-IR) spectral studies revealed no incompatibility between the pure drug and selected polymers. The spherical nature of the prepared microcapsules was established by surface morphology studies. Conclusion: The resultant sustained release mucoadhesive microcapsules of ramipril remained stable when subjected to stress conditions unveiling it as a better alternative delivery system with superior therapeutic efficacy.
机译:目的:本研究的主要目的是通过离子凝胶法设计,优化和表征基于海藻酸钠的雷米普利缓释粘膜粘附微胶囊。方法:设计了一个实验装置,以研究粘膜粘附聚合物(如carbopol 974P,?HPMC?(K4M和?K100M),Na CMC和壳聚糖)的最佳组合及其药物相容性。配方变量的初步筛选是通过Taguchi设计,然后是Box-Behnken设计进行的系统优化。选择合适的数学模型,进行响应面分析,并通过数值优化和期望函数法选择优化配方。制备的微胶囊具有多种固有特性的表征,例如粒径,药物含量,球形度,包封效率,松散的表面晶体研究,溶胀指数,微团性质,水分含量,体外药物释放,粘膜粘附强度和体内抗高血压活性被执行了。结果:差示扫描量热法(DSC)热谱图和傅立叶变换红外(FT-IR)光谱研究表明,纯药物与所选聚合物之间没有不相容性。通过表面形态研究确定了制备的微胶囊的球形性质。结论:雷米普利产生的持续释放的粘膜粘附性微胶囊在应激条件下保持稳定,这表明它是一种具有更好治疗效果的更好的替代给药系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号